Stockreport

Alkermes CEO Pops Calls 2026 a “Really Exciting Year” as Orexin Agonists Near Narcolepsy Launch [Yahoo! Finance]

Alkermes plc - Ordinary Shares  (ALKS) 
Last alkermes plc - ordinary shares earnings: 4/29 07:00 am Check Earnings Report
PDF year” that will set the class price and launch trajectory; Alkermes plans to differentiate on patient-centric dosing by launching a range of once-daily doses and split d [Read more]